Insider Transactions in Q4 2020 at Lixte Biotechnology Holdings, Inc. (LIXT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Eric Forman Vice President and COO |
BUY
Bona fide gift
|
Direct |
2,900
+12.91%
|
-
|
|
Nov 30
2020
|
Hung Tak Ho > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
42,105
+3.88%
|
$168,420
$4.75 P/Share
|
|
Nov 30
2020
|
Gil Schwartzberg Director |
BUY
Open market or private purchase
|
Direct |
105,264
+29.82%
|
$421,056
$4.75 P/Share
|
|
Nov 30
2020
|
Yun Yen Director |
BUY
Open market or private purchase
|
Indirect |
52,632
+50.0%
|
$210,528
$4.75 P/Share
|
|
Nov 30
2020
|
Stephen J. Forman Director |
BUY
Open market or private purchase
|
Indirect |
21,053
+35.82%
|
$84,212
$4.75 P/Share
|
|
Nov 30
2020
|
Philip F Palmedo Director |
BUY
Open market or private purchase
|
Direct |
21,053
+39.64%
|
$84,212
$4.75 P/Share
|
|
Nov 30
2020
|
Robert Greenberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
52,632
+5.03%
|
$210,528
$4.75 P/Share
|
|
Nov 30
2020
|
John S Kovach President and CEO |
BUY
Open market or private purchase
|
Indirect |
21,100
+1.35%
|
$84,400
$4.75 P/Share
|